6.
Timmermann B, Kortmann R, Kuhl J, Meisner C, Slavc I, Pietsch T
. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys. 2000; 46(2):287-95.
DOI: 10.1016/s0360-3016(99)00414-9.
View
7.
Ellison D, Aldape K, Capper D, Fouladi M, Gilbert M, Gilbertson R
. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathol. 2020; 30(5):863-866.
PMC: 8018155.
DOI: 10.1111/bpa.12866.
View
8.
Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W
. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20.
DOI: 10.1007/s00401-016-1545-1.
View
9.
Merchant T, Li C, Xiong X, Kun L, Boop F, Sanford R
. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009; 10(3):258-66.
PMC: 3615425.
DOI: 10.1016/s1470-2045(08)70342-5.
View
10.
Rodriguez D, Cheung M, Housri N, Quinones-Hinojosa A, Camphausen K, Koniaris L
. Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005). J Surg Res. 2009; 156(2):340-51.
PMC: 7371344.
DOI: 10.1016/j.jss.2009.04.024.
View
11.
Chen Y, Tian T, Guo X, Zhang F, Fan M, Jin H
. Polymorphous low-grade neuroepithelial tumor of the young: case report and review focus on the radiological features and genetic alterations. BMC Neurol. 2020; 20(1):123.
PMC: 7137220.
DOI: 10.1186/s12883-020-01679-3.
View
12.
Paredes-Aragon E, Alkhaldi N, Burneo J, Lee D, Ang L, Steven D
. Pearls & Oy-sters: Salt and Pepper Sign, PLNTY for Drug-Resistant Epilepsy. Neurology. 2022; 100(16):791-795.
PMC: 10115500.
DOI: 10.1212/WNL.0000000000206782.
View
13.
Kim S, Lee Y, Kim S, Kang H, Park S
. Aggressive Supratentorial Ependymoma, RELA Fusion-Positive with Extracranial Metastasis: A Case Report. J Pathol Transl Med. 2017; 51(6):588-593.
PMC: 5700879.
DOI: 10.4132/jptm.2017.08.10.
View
14.
Palejwala A, ONeal C, Quinton M, Battiste J, Peterson J, Dunn I
. Polymorphous low-grade neuroepithelial tumor of the young: Rare tumor and review of the literature. Rare Tumors. 2022; 14:20363613221083360.
PMC: 8966082.
DOI: 10.1177/20363613221083360.
View
15.
Ryall S, Zapotocky M, Fukuoka K, Nobre L, Stucklin A, Bennett J
. Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas. Cancer Cell. 2020; 37(4):569-583.e5.
PMC: 7169997.
DOI: 10.1016/j.ccell.2020.03.011.
View
16.
Huse J, Snuderl M, Jones D, Brathwaite C, Altman N, Lavi E
. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol. 2016; 133(3):417-429.
PMC: 5325850.
DOI: 10.1007/s00401-016-1639-9.
View
17.
Mariet C, Castel D, Grill J, Saffroy R, Dangouloff-Ros V, Boddaert N
. Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis. Acta Neuropathol Commun. 2022; 10(1):137.
PMC: 9476256.
DOI: 10.1186/s40478-022-01442-4.
View
18.
Yang Z, Wang K
. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015; 38(6):364-74.
PMC: 4559283.
DOI: 10.1016/j.tins.2015.04.003.
View
19.
McGuire C, Sainani K, Fisher P
. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg. 2008; 110(4):725-9.
DOI: 10.3171/2008.9.JNS08117.
View